INS and type 2 diabetes mellitus: Capillary blood glucose monitoring (CBG) monitoring was the standard of care before 2022, when NICE (National Institute for Health and Care Excellence) recommended CGM in all people living with T1DM and those with T2DM who are on multiple daily insulin injections with an elevated risk of hypoglycaemia, among other criteria.6